Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
Shire, 03/23/09

Shire plc, the global specialty biopharmaceutical company, announced a voluntary market withdrawal/recall of thirty-nine (39) lots of the ADHD patch DAYTRANA. Shire is taking this action because some DAYTRANA patches no longer meet their release liner removal specification, and as a result, patients and caregivers could have difficulties removing the liners.

Today in Marketing/Media/ROI...keeping you current

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

 See all of Marketing/Media/ROI

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address